Cancer patients who got an mRNA COVID vaccine within a few months of their immunotherapy lived longer than those who did not, health records show.

Researchers found that COVID-19 mRNA vaccines significantly increased survival in lung and skin cancer patients undergoing ...

The researchers found that mRNA-based COVID-19 vaccines could potentially help patients whose tumors don’t respond well to ...

The study, published in the journal Nature, showed the jabs provided an immunity boost that helped extend survival for ...

The observation that mRNA vaccines can sensitize tumors to immunotherapy has researchers eager to test how mRNA’s ability to activate the immune system could be harnessed in oncology.

People with advanced lung or skin cancer who were taking certain immunotherapy drugs lived substantially longer if they also ...

Cancer patients who received mRNA-based COVID vaccines within 100 days of starting treatment with widely used immunotherapies ...

University of Florida researchers found that advanced lung and skin cancer patients lived “significantly longer” after ...

Moderna, Inc. (NASDAQ:MRNA) today announced it was ranked as a top employer in the global biopharmaceutical industry in ...

Small study looks only at a cardiac biomarker; findings are in line with reduced myocarditis risk in mRNA COVID vaccines ...

Over the last year, Noubar Afeyan has watched Cambridge-based Moderna go from perhaps the world’s most celebrated company to a target of government officials promoting falsehoods about mRNA technology ...